Investors - Aldeyra Therapeutics, Inc.

The Investor Relations website contains information about Aldeyra Therapeutics, Inc. business for stockholders, potential investors, and financial analysts.

OVERVIEW

This domain ir.aldeyra.com currently has an average traffic classification of zero (the lower the superior). We have sifted ten pages within the domain ir.aldeyra.com and found eighteen websites linking to ir.aldeyra.com.
Pages Analyzed
10
Links to this site
18

IR.ALDEYRA.COM RANKINGS

This domain ir.aldeyra.com has seen fluctuating quantities of traffic all round the year.
Traffic for ir.aldeyra.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.aldeyra.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.aldeyra.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB PAGE

Aldeyra Therapeutics Capturing Health

We are developing a novel drug platform of drug candidates designed to trap aldehydes toxic chemical species implicated in many serious diseases. With a family of chemical entities, Aldeyra is first focusing on orphan diseases thought to be related to aldehydes. To stay informed on future news, click here to sign-up.

WHAT DOES IR.ALDEYRA.COM LOOK LIKE?

Desktop Screenshot of ir.aldeyra.com Mobile Screenshot of ir.aldeyra.com Tablet Screenshot of ir.aldeyra.com

IR.ALDEYRA.COM HOST

We identified that a single root page on ir.aldeyra.com took two hundred and ninety-seven milliseconds to load. I could not discover a SSL certificate, so in conclusion I consider this site not secure.
Load time
0.297 seconds
SSL
NOT SECURE
Internet Address
206.200.251.19

TITLE

Investors - Aldeyra Therapeutics, Inc.

DESCRIPTION

The Investor Relations website contains information about Aldeyra Therapeutics, Inc. business for stockholders, potential investors, and financial analysts.

CONTENT

This domain ir.aldeyra.com states the following, "Aldeyra Therapeutics is a clinical-stage biotechnology company focused primarily on the development of products to treat diseases thought to be related to endogenous free aldehydes, a naturally occurring class of toxic molecules." Our analyzers observed that the webpage also stated " The company has developed NS2, a product candidate designed to trap free aldehydes." The Website also stated " Aldeyra has initiated clinical testing of NS2 for the treatment of Sjögren-Larsson Syndrome and noninfectious anterior uveitis. Aldeyra Therapeutics Corporate Presentation - August 2015."

VIEW OTHER DOMAINS

Weeroot Digital Agency

Εμφυτεύουμε ιδέες και δημιουργούμε συναρπαστικές εμπειρίες. Πιστεύουμε πολύ στους ανθρώπους μας και στο ευρύ φάσμα δεξιοτήτων, που συνδυαζόμενο με τη δημιουργικότητα φέρνει στο τραπέζι τις μεγαλύτερες και πιο τρελές ιδέες. The man with the idea. The man of the next day. The man with the idea. The man of the next day. Μερικά από τα βασικά συστατικά μας σε αριθμούς. Χρειάζεστε μία αποτελεσματική καμπάνια email; Τέλεια. Εμείς αναλαμβάνουμε τη σχεδίαση, το περιεχόμενο και .

Alderspillen

Lagt inn av Dag Einar Vistad Hansen.

Free WordPress Themes PurelyThemes - We develop WordPress themes

This theme will meet most needs when designing a website for any commercial, corporate or even personal purposes. With more than 110 different customization options built into the live theme viewer it is easy to make your own unique combination of sections using load ordering. Some of our latest themes. Click around, see if you find a template that you like! We create WordPress Themes. You can also go straight to the WooCommerce Themes.